Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis-Reference-Cited by-同舟云学术

Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis

Published:2019-01 Issue: Volume:27 Page:44-45
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Buonomo Antonio Riccardo^ORCID,Saccà Francesco^ORCID,Zappulo Emanuela,De Zottis Federico,Lanzillo Roberta,Gentile Ivan,Carotenuto Antonio^ORCID,Borgia Guglielmo,Russo Cinzia Valeria

Publisher

Elsevier BV

Reference6 articles.

1. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL;Gallamini;Blood,2007

2. Updated guidelines on the management of Cytomegalovirus reactivation in patients with chronic Lymphocytic Leukemia treated with Alemtuzumab;O'Brien;Clin. Lymphoma Myeloma,2006

3. Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis;Buonomo;Expert Opin. Drug Saf [Internet],2018

4. Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab;Clerico;Mult. Scler. J,2017

5. Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment;Barone;Mult. Scler. Relat. Disord,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis;Multiple Sclerosis and Related Disorders;2022-07

2. Cytomegalovirus and Other Herpesviruses;Infectious Complications in Biologic and Targeted Therapies;2022

3. Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies;Expert Opinion on Drug Safety;2021-07-26

4. Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project;Pharmaceuticals;2020-12-15

5. Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies;Clinical Microbiology Reviews;2020-06-17